Immunic Inc. (IMUX) Misses Q2 EPS by 3c

Immunic Inc. (NASDAQ: IMUX) reported Q2 EPS of ($0.20), $0.03 worse than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

You May Also Be Interested In

• Calix, Inc. (CALX) Tops Q2 EPS by 6c, Offers Guidance
• U.S. to impose 50% tariff on most Canadian goods, including USMCA
• Krystal Biotech to join S&P MidCap 400, Tutor Perini and V2X to join S&P SmallCap 600